Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Muthu Veeraputhiran

Concepts (110)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
9
2023
565
2.050
Why?
Hematologic Neoplasms
2
2021
99
0.820
Why?
Blood Platelets
3
2011
245
0.720
Why?
Transplantation Conditioning
2
2017
83
0.690
Why?
Hematopoietic Stem Cells
2
2011
184
0.670
Why?
Comorbidity
1
2017
615
0.510
Why?
Leukocytes
2
2011
66
0.480
Why?
Melphalan
1
2015
174
0.480
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2014
56
0.470
Why?
Granulocyte Colony-Stimulating Factor
1
2014
61
0.460
Why?
Hematopoietic Stem Cell Mobilization
1
2014
57
0.460
Why?
Cyclophosphamide
1
2014
165
0.450
Why?
Hemagglutination Tests
1
2011
7
0.400
Why?
Aldehyde Dehydrogenase
1
2011
26
0.400
Why?
Graft vs Host Disease
2
2023
75
0.400
Why?
Isoantibodies
1
2011
27
0.390
Why?
Transplantation, Autologous
4
2015
466
0.380
Why?
Plateletpheresis
1
2010
7
0.370
Why?
Blood Preservation
1
2010
26
0.370
Why?
Cryopreservation
1
2010
31
0.360
Why?
Blood Proteins
1
2010
82
0.360
Why?
Anaphylaxis
1
2010
71
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
989
0.330
Why?
Rhabdomyolysis
1
2008
12
0.320
Why?
Simvastatin
1
2008
29
0.310
Why?
Anticholesteremic Agents
1
2008
28
0.310
Why?
Quinazolines
1
2008
33
0.310
Why?
Multiple Myeloma
2
2015
2929
0.310
Why?
Protein Kinase Inhibitors
1
2008
204
0.280
Why?
Pyrazoles
2
2023
113
0.260
Why?
Time Factors
1
2010
2903
0.230
Why?
Acetamides
1
2023
20
0.230
Why?
Platelet Transfusion
2
2015
28
0.220
Why?
Humans
14
2023
49974
0.210
Why?
Aged
6
2017
9310
0.210
Why?
Antigens, CD34
2
2011
66
0.190
Why?
Cell Count
2
2011
147
0.190
Why?
Adult
6
2017
13236
0.180
Why?
Graft Survival
2
2011
150
0.180
Why?
Heart Rate
1
2021
293
0.180
Why?
Retrospective Studies
4
2017
6108
0.170
Why?
Cell Survival
2
2011
600
0.170
Why?
Liver Transplantation
1
2020
148
0.160
Why?
Incidence
1
2021
1003
0.160
Why?
Middle Aged
4
2017
12069
0.150
Why?
Cytomegalovirus Infections
1
2017
34
0.150
Why?
Transplantation, Homologous
1
2017
139
0.140
Why?
Appendicitis
1
2017
59
0.140
Why?
Regression Analysis
1
2017
395
0.140
Why?
Antineoplastic Agents, Alkylating
1
2016
74
0.140
Why?
Dendritic Cells
1
2016
133
0.130
Why?
Carmustine
1
2015
12
0.130
Why?
Postoperative Hemorrhage
1
2015
51
0.130
Why?
Cytarabine
1
2015
39
0.130
Why?
Etoposide
1
2015
72
0.130
Why?
Bronchoscopy
1
2015
71
0.130
Why?
Thrombocytopenia
1
2015
85
0.120
Why?
Survival Rate
1
2017
894
0.120
Why?
Salvage Therapy
1
2015
139
0.120
Why?
Drug Substitution
1
2014
9
0.120
Why?
Blood Cell Count
1
2014
37
0.120
Why?
Drug Evaluation
1
2014
26
0.120
Why?
Benzylamines
1
2014
15
0.120
Why?
Disease-Free Survival
1
2015
454
0.120
Why?
Heterocyclic Compounds
1
2014
28
0.120
Why?
Drug Synergism
1
2014
150
0.110
Why?
Risk Assessment
1
2017
1259
0.110
Why?
Nitriles
2
2023
54
0.100
Why?
Prognosis
1
2017
1942
0.100
Why?
Immune Tolerance
1
2011
96
0.100
Why?
Skin Neoplasms
1
2016
488
0.090
Why?
Dimethyl Sulfoxide
1
2010
12
0.090
Why?
Pyrimidines
2
2023
192
0.090
Why?
Isotonic Solutions
1
2010
18
0.090
Why?
P-Selectin
1
2010
32
0.090
Why?
Sodium Chloride
1
2010
57
0.090
Why?
Platelet Aggregation
1
2010
71
0.090
Why?
Platelet Activation
1
2010
46
0.090
Why?
Feasibility Studies
1
2011
375
0.090
Why?
Male
5
2017
25241
0.090
Why?
Hypersensitivity
1
2010
77
0.090
Why?
Female
4
2015
26472
0.080
Why?
Sensitivity and Specificity
1
2011
861
0.080
Why?
Atenolol
1
2008
14
0.080
Why?
Azetidines
1
2008
6
0.080
Why?
Amlodipine
1
2008
14
0.080
Why?
Hyperlipidemias
1
2008
49
0.080
Why?
Drug Interactions
1
2008
206
0.080
Why?
Young Adult
1
2017
3958
0.080
Why?
Antihypertensive Agents
1
2008
117
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
121
0.070
Why?
Aspirin
1
2008
114
0.070
Why?
Carcinoma, Non-Small-Cell Lung
1
2008
154
0.070
Why?
Coronary Artery Disease
1
2008
274
0.060
Why?
Neoplasm Recurrence, Local
1
2008
614
0.060
Why?
Hypertension
1
2008
533
0.050
Why?
Tomography, X-Ray Computed
1
2008
1159
0.050
Why?
Lung Neoplasms
1
2008
606
0.050
Why?
Chronic Disease
1
2023
567
0.050
Why?
Child
1
2011
6847
0.040
Why?
Ganciclovir
1
2017
24
0.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.030
Why?
Antiviral Agents
1
2017
173
0.030
Why?
Platelet Count
1
2015
72
0.030
Why?
Leukemia, Myeloid, Acute
1
2016
185
0.030
Why?
Bone Marrow
1
2016
362
0.030
Why?
Biopsy
1
2016
584
0.030
Why?
Practice Guidelines as Topic
1
2015
449
0.030
Why?
Antineoplastic Agents
1
2017
1171
0.020
Why?
Aged, 80 and over
1
2015
3129
0.020
Why?
Veeraputhiran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description